Opendata, web and dolomites

INTERfaces SIGNED

Heterogenous biocatalytic reaction cascades training network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INTERfaces project word cloud

Explore the words cloud of the INTERfaces project. It provides you a very rough idea of what is the project "INTERfaces" about.

emphasizes    tech    biobased    titers    improvement    catalytic    train    environment    engineering    reaction    innovative    14    solid    reactions    supervisory    diversity    biotech    immobilized    synthetic    combines    synthesize    jointly    environmental    time    re    avoiding    enzymes    cascades    producing    desired    workshops    assembly    materials    modes    material    smes    esrs    obtain    complement    monomers    downstream    extension    form    intersectoral    bio    protein    chemicals    ph    yields    starting    simplify    bioprocesses    companies    balanced    outstanding    isolation    optimization    biocatalytic    intermediates    science    reveal    modeling    designed    purification    clean    industry    antioxidants    optimized    footprint    catalysts    sequences    tools    gender    medium    heterogeneous    eid    interdisciplinary    computational    biocatalysts    right    interfaces    13    candidates    profiles    employability    scaled    team    space    biopolymers    reactors    academic    network    ranging    commercial   

Project "INTERfaces" data sheet

The following table provides information about the project.

Coordinator
AARHUS UNIVERSITET 

Organization address
address: NORDRE RINGGADE 1
city: AARHUS C
postcode: 8000
website: www.au.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 3˙709˙260 €
 EC max contribution 3˙709˙260 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-EID
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AARHUS UNIVERSITET DK (AARHUS C) coordinator 595˙044.00
2    VIAZYM BV NL (DELFT) participant 531˙239.00
3    ENGINZYME AB SE (STOCKHOLM) participant 281˙982.00
4    ACIB GMBH AT (GRAZ) participant 264˙207.00
5    TECHNISCHE UNIVERSITAET GRAZ AT (GRAZ) participant 264˙207.00
6    UNIVERSITA DEGLI STUDI DI TRIESTE IT (TRIESTE) participant 261˙499.00
7    CASCAT GMBH DE (STRAUBING) participant 252˙788.00
8    HENKEL KGaA DE (DUSSELDORF) participant 252˙788.00
9    UNIVERSITAET BIELEFELD DE (BIELEFELD) participant 252˙788.00
10    AENEAM ADVANCED MEMBRANE TECHNOLOGIES ES (ZARAGOZA) participant 250˙904.00
11    UNIVERSIDAD DE OVIEDO ES (OVIEDO) participant 250˙904.00
12    UNIVERSIDAD DE ZARAGOZA ES (ZARAGOZA) participant 250˙904.00
13    BIOPOX SRL IT (NAPOLI) participant 0.00
14    KUNGLIGA TEKNISKA HOEGSKOLAN SE (STOCKHOLM) participant 0.00
15    MICRONIT MICROTECHNOLOGIES BV NL (ENSCHEDE) participant 0.00
16    NANOMATERIALES Y POLIMEROS SL ES (ARMILLA GRANADA) participant 0.00
17    SPINCHEM AB SE (UMEA) participant 0.00

Map

 Project objective

The INTERfaces program will train 14 ESRs within an EID network jointly designed by European academic and industry partners in innovative research projects dedicated to developing clean bioprocesses for the production of chemicals. The assembly of biocatalysts to reaction sequences allows avoiding steps for isolation and purification of intermediates and thus a significant improvement of the environmental footprint of catalytic processes. The main goal of INTERfaces is the extension of this concept towards multi-step biocatalytic reactions in immobilized form. These “Heterogeneous Biocatalytic Reaction Cascades” will greatly facilitate re-use of the catalysts and further simplify downstream-processing. INTERfaces combines material science and protein engineering to design tailored enzymes and (bio-based) materials that will complement each other to obtain optimized heterogeneous biocatalysts. These tools will be applied to solve synthetic challenges in the use of two biobased monomers as starting materials to synthesize products for application fields like antioxidants and biopolymers. Process optimization and up-scale in industry will reveal key factors for synthetic utilization of the biocatalysts. INTERfaces emphasizes particularly the engineering of the designed cascades in solid phase. This includes the design of reactors, use of computational modeling tools, application of the right operational modes, and reaction medium needed for desired space-time-yields and product titers. Commercial relevant processes will be up-scaled together with industry for technical implementation. 13 Non-academic partners ranging from high-tech SMEs to large producing companies and 9 academic institutions offer an intersectoral and interdisciplinary environment to provide 14 Ph.D. candidates with outstanding employability profiles for the European Biotech Sector. Dedicated workshops and well-balanced supervisory team aim at increasing the gender diversity in biotech research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTERFACES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INTERFACES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

WON (2019)

Wideband Optical Networks

Read More